Biotin Solution for Injection recalled due to lack of sterility assurance
ASP CARES is recalling Biotin Solution for Injection (10 mg/mL, 30 mL vials) because the manufacturer cannot assure the product's sterility. The affected lot was distributed in the United States.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class II. The hazard involves lack of sterility assurance in an injectable drug product administered directly into the body, which poses a significant potential for serious adverse outcomes including infection and sepsis. Although no illnesses or injuries are reported in the source text, the nature of the hazard and the product classification meet the criteria for a Severe rating.
Plain-English summary
ASP CARES is recalling Biotin Solution for Injection, 10 mg/mL, 30 mL Multiple Dose Vial, Sterile, For IM or IV use only (NDC 72833-0589-30) due to lack of assurance of sterility.
The recalled product consists of 896 vials from Lot 091721589, with a beyond-use date of 03/16/2022. The product was distributed throughout the United States.
Because the sterility of this injectable medication cannot be assured, there is a potential risk to patients who receive it. Sterility is a critical requirement for injectable products. Healthcare providers and patients who have received this product should contact their healthcare provider for guidance. The product should not be used.
For additional information, consumers and healthcare providers may contact ASP CARES at 2414 Babcock Rd Ste #106, San Antonio, TX 78229.
The recalled product
- Product
- Biotin Solution for Injection, 10 mg/mL, 30 mL Multiple Dose Vial, Sterile, For IM or IV use only, Rx only ASP Cares, 2414 Babcock Rd Ste #106, San Antonio, TX 78229 NDC 72833-0589-30
- Manufacturer
- ASP CARES
- Category
- Drug — Injectable / Vitamin
- Hazard
- lack-of-sterility
- potential-infection
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 091721589 BUD: 03/16/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27